Despite the heterogeneity of HNSCC included in the series of patients herein analysed, which is certainly a limitation of the study, our findings suggest that integrin-β1 and Oct4 are stem cell markers for HNSCC linked with resistance to radiotherapy. Here, POU5F1 is linked to head and neck squamous cell carcinoma.